Other Diseases

ImaginAb has collaborated with AstraZeneca, Pfizer and Takeda to develop technology to facilitate tumour imaging and monitoring inside the cells. ImaginAb is an emerging imaging company focused on immune-oncology. The technology also helps in targeting and visualizing CD8+ T cells, which are activated by the immunotherapy and induce cell death. Under the terms of the agreement, the collaborators will advance the current ImaginAb-sponsored clinical trials that aim to study the utility and value of CD8 ImmunoPet in the immune-oncology pipeline. In return, collaborators will gain access to data of clinical and imaging data that will help them analyse the post...